Assyro AI

FDA Orange Book · active-ingredient family

Doxepin hydrochloride

Doxepin hydrochloride is approved as 5 brand and 78 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:SILENOR · NDA 022036

5

Brand (NDA)

78

Generics (ANDA)

16

Listed patents

0

Exclusivity periods

Brand (NDA) products · capsule, concentrate, cream, tablet

ProductApplicantApplicationTEApproved
SILENORRLD×2CURRAXNDA 022036ABMar 17, 2010
ZONALONRLDMYLANNDA 020126ABApr 01, 1994
SINEQUANRLD×6PFIZERNDA 016798Approved Prior to Jan 1, 1982
SINEQUANRLDPFIZERNDA 017516Approved Prior to Jan 1, 1982
DOXEPIN HYDROCHLORIDE×6NEW RIVERNDA 016987Approved Prior to Jan 1, 1982

Generic (ANDA) products (78)

ProductApplicantApplicationTEApproved
DOXEPIN HYDROCHLORIDESUN PHARMA CANADAANDA 213919ABApr 28, 2026
DOXEPIN HYDROCHLORIDE×2TAROANDA 219058ABAug 06, 2025
DOXEPIN HYDROCHLORIDE×2AUROBINDO PHARMA LTDANDA 216041ABJul 25, 2024
DOXEPIN HYDROCHLORIDE×2AJANTA PHARMA LTDANDA 218564ABJul 01, 2024
DOXEPIN HYDROCHLORIDE×5UNIQUEANDA 217975ABAug 21, 2023
DOXEPIN HYDROCHLORIDEAMNEALANDA 212357ABAug 16, 2023
DOXEPIN HYDROCHLORIDE×2ZYDUS LIFESCIENCESANDA 202761ABAug 16, 2023
DOXEPIN HYDROCHLORIDE×5MICRO LABSANDA 217688ABJun 27, 2023
DOXEPIN HYDROCHLORIDE×2MSNANDA 214823BXApr 03, 2023
DOXEPIN HYDROCHLORIDE×5ZYDUS LIFESCIENCESANDA 210700BXMar 23, 2023
DOXEPIN HYDROCHLORIDEZYDUS LIFESCIENCESANDA 210140BXMar 21, 2023
DOXEPIN HYDROCHLORIDETEVA PHARMSANDA 215408ABFeb 17, 2023
DOXEPIN HYDROCHLORIDE×5MSNANDA 215113ABJun 24, 2022
DOXEPIN HYDROCHLORIDEADAPTISANDA 213796Apr 19, 2022
DOXEPIN HYDROCHLORIDE×5JUBILANT CADISTAANDA 215483ABMar 14, 2022
DOXEPIN HYDROCHLORIDE×5MANKIND PHARMAANDA 215710ABFeb 09, 2022
DOXEPIN HYDROCHLORIDE×5ALEMBICANDA 215076ABApr 21, 2021
DOXEPIN HYDROCHLORIDE×5APPCOANDA 214908ABApr 01, 2021
DOXEPIN HYDROCHLORIDE×5IXORA LIFESCIENCEANDA 211619ABMar 09, 2021
DOXEPIN HYDROCHLORIDEVELZEN PHARMA PVTANDA 211618ABMar 01, 2021
DOXEPIN HYDROCHLORIDE×5EPIC PHARMA LLCANDA 210675ABOct 16, 2020
DOXEPIN HYDROCHLORIDE×5CHARTWELL RXANDA 210268ABSep 04, 2020
DOXEPIN HYDROCHLORIDE×5AIPING PHARM INCANDA 213474ABJul 28, 2020
DOXEPIN HYDROCHLORIDE×5LANNETT CO INCANDA 212997Jul 24, 2020
DOXEPIN HYDROCHLORIDE×2STRIDES PHARMA INTLANDA 202510ABJul 24, 2020
DOXEPIN HYDROCHLORIDE×5TAROANDA 213063Jul 01, 2020
DOXEPIN HYDROCHLORIDE×5AJANTA PHARMA LTDANDA 212624ABSep 13, 2019
DOXEPIN HYDROCHLORIDE×5AUROBINDO PHARMA LTDANDA 211603ABMar 27, 2019
DOXEPIN HYDROCHLORIDE×5AMNEAL PHARMS COANDA 207482ABJun 28, 2017
DOXEPIN HYDROCHLORIDE×2RK PHARMAANDA 202337ABJan 20, 2016
DOXEPIN HYDROCHLORIDE×2ACTAVIS ELIZABETHANDA 201951ABJul 26, 2013
DOXEPIN HYDROCHLORIDEPHARM ASSOCANDA 075924Jan 15, 2004
DOXEPIN HYDROCHLORIDELANNETT CO INCANDA 074721Dec 29, 1998
DOXEPIN HYDROCHLORIDEWATSON LABSANDA 072985Mar 29, 1991
DOXEPIN HYDROCHLORIDEWATSON LABSANDA 072986Mar 29, 1991
DOXEPIN HYDROCHLORIDEWATSON LABS TEVAANDA 072987Mar 29, 1991
DOXEPIN HYDROCHLORIDEPUREPAC PHARMANDA 073054Dec 28, 1990
DOXEPIN HYDROCHLORIDEPUREPAC PHARMANDA 072109Dec 28, 1990
DOXEPIN HYDROCHLORIDEPUREPAC PHARMANDA 073055Dec 28, 1990
DOXEPIN HYDROCHLORIDEQUANTUM PHARMICSANDA 072375Mar 15, 1989
DOXEPIN HYDROCHLORIDEQUANTUM PHARMICSANDA 072376Mar 15, 1989
DOXEPIN HYDROCHLORIDEPUREPAC PHARMANDA 072386Sep 08, 1988
DOXEPIN HYDROCHLORIDEPUREPAC PHARMANDA 072110Sep 08, 1988
DOXEPIN HYDROCHLORIDEPUREPAC PHARMANDA 072387Sep 08, 1988
DOXEPIN HYDROCHLORIDEPHARMOBEDIENT CNSLTGANDA 071918Jul 20, 1988
DOXEPIN HYDROCHLORIDESUN PHARM INDUSTRIESANDA 071502Feb 18, 1988
DOXEPIN HYDROCHLORIDESUN PHARM INDUSTRIESANDA 071653Feb 18, 1988
DOXEPIN HYDROCHLORIDESUN PHARM INDUSTRIESANDA 071654Feb 18, 1988
DOXEPIN HYDROCHLORIDESUN PHARM INDUSTRIESANDA 071521Feb 18, 1988
DOXEPIN HYDROCHLORIDEWATSON LABSANDA 071763Feb 09, 1988
DOXEPIN HYDROCHLORIDEWATSON LABSANDA 071764Feb 09, 1988
DOXEPIN HYDROCHLORIDEDAVA PHARMS INCANDA 071685Jan 05, 1988
DOXEPIN HYDROCHLORIDEDAVA PHARMS INCANDA 071686Jan 05, 1988
DOXEPIN HYDROCHLORIDEDAVA PHARMS INCANDA 071673Jan 05, 1988
DOXEPIN HYDROCHLORIDEDAVA PHARMS INCANDA 071674Jan 05, 1988
DOXEPIN HYDROCHLORIDEDAVA PHARMS INCANDA 071675Jan 05, 1988
DOXEPIN HYDROCHLORIDEDAVA PHARMS INCANDA 071676Jan 05, 1988
DOXEPIN HYDROCHLORIDE×6PH HEALTHANDA 071422Nov 09, 1987
DOXEPIN HYDROCHLORIDETEVA PHARMSANDA 071609Nov 09, 1987
DOXEPIN HYDROCHLORIDEQUANTUM PHARMICSANDA 070972Sep 29, 1987
DOXEPIN HYDROCHLORIDEQUANTUM PHARMICSANDA 070973Sep 29, 1987
DOXEPIN HYDROCHLORIDEQUANTUM PHARMICSANDA 070931Sep 29, 1987
DOXEPIN HYDROCHLORIDEQUANTUM PHARMICSANDA 070932Sep 29, 1987
DOXEPIN HYDROCHLORIDEWATSON LABSANDA 071485Apr 30, 1987
DOXEPIN HYDROCHLORIDEWATSON LABSANDA 071486Apr 30, 1987
DOXEPIN HYDROCHLORIDEWATSON LABSANDA 071238Apr 30, 1987
DOXEPIN HYDROCHLORIDEWATSON LABSANDA 071326Apr 30, 1987
DOXEPIN HYDROCHLORIDEWATSON LABSANDA 071239Apr 30, 1987
DOXEPIN HYDROCHLORIDEWATSON LABSANDA 070952Mar 04, 1987
DOXEPIN HYDROCHLORIDESANDOZANDA 071487Mar 02, 1987
DOXEPIN HYDROCHLORIDESANDOZANDA 071562Mar 02, 1987
DOXEPIN HYDROCHLORIDESANDOZANDA 070827May 15, 1986
DOXEPIN HYDROCHLORIDESANDOZANDA 070828May 15, 1986
DOXEPIN HYDROCHLORIDESANDOZANDA 070825May 15, 1986
DOXEPIN HYDROCHLORIDEWATSON LABSANDA 070953May 15, 1986
DOXEPIN HYDROCHLORIDEWATSON LABSANDA 070954May 15, 1986
DOXEPIN HYDROCHLORIDEWATSON LABSANDA 070955May 15, 1986
DOXEPIN HYDROCHLORIDE×5MYLAN PHARMS INCANDA 070791ABMay 13, 1986

Listed patents (16)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
9861607May 18, 2027in 11 mo
U-620
12083090May 18, 2027in 11 mo
U-620
9486437May 18, 2027in 11 mo
U-620
10238620May 18, 2027in 11 mo
U-620
10653662May 18, 2027in 11 mo
U-620
9572814Jul 20, 2027in 1 yr 1 mo
U-620
10653660Jul 20, 2027in 1 yr 1 mo
U-620
11110074Jul 20, 2027in 1 yr 1 mo
U-620
7915307Aug 24, 2027in 1 yr 2 mo
U-620
11234954Jan 18, 2028in 1 yr 7 mo
U-620
10548871Apr 11, 2028in 1 yr 10 mo
U-620
11096920Apr 11, 2028in 1 yr 10 mo
U-620
9907780Apr 11, 2028in 1 yr 10 mo
Product
9107898May 01, 2028in 1 yr 11 mo
U-620
9532971Jun 01, 2029in 3 yr
Product
8513299Sep 07, 2030in 4 yr 3 mo
U-620

Doxepin hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.